Dutch biotech firm Polyganics has secured €1.2 million in funding to support the clinical development of its dura sealant patch.
The funding comes from the European Fund for Regional Development by the EU, with an additional grant from the city and province of Groningen in the Netherlands.
The device has been developed using Polyganics’ proprietary bioresorbable polymers, creating a dressing suitable for resealing the outer membrane (‘dura’) surrounding the brain after brain surgery, minimizing leakage of cerebrospinal fluid.
The dressing has been engineered to encourage tissue regeneration, and to degrade naturally and safely within the body over time, once the membrane has healed.
Polyganics is developing its dura sealant patch under a collaboration with the Brain Technology Institute and Syncom, a contract research organisation located in Groningen.
Following recently completed animal studies of the dura sealant patch, Polyganics is currently finalizing preparations for the start of a clinical study, to demonstrate safety and performance in humans.
Rudy Mareel, CEO of Polyganics, said: “The work has important implications for improved recovery following brain surgery, including helping to prevent potentially fatal complications such as meningitis.”